AMERICAN HEART JOURNAL

AMERICAN HEART JOURNAL Journal

publication venue for

Characterizing advanced heart failure risk and hemodynamic phenotypes using interpretable machine learning. 271:1-11. 2024
CATALYST: A Phase 4 Study of Hypercortisolism in Patients with Difficult-to-Control Type 2 Di- abetes Despite Receiving Standard-of-Care Ther- apies Assessing Prevalence and Treatment with Mifepristone. 267:134-135. 2023
PredischaRge initiation of Ivabradine in the ManagEment of Heart Failure: Results of the PRIME-HF Trial. 223:98-105. 2020
Comorbidities and the decision to undergo or forego destination therapy left ventricular assist device implantation: An analysis from the Trial of a Shared Decision Support Intervention for Patients and their Caregivers Offered Destination Therapy for End-Stage Heart Failure (DECIDE-LVAD) study. 213:91-96. 2019
Design and baseline characteristics of the eValuation of ERTugliflozin effIcacy and Safety CardioVascular outcomes trial (VERTIS-CV). 206:11-23. 2018
Palliative care and hospital readmissions in patients with advanced heart failure: Insights from the PAL-HF trial. 204:202-204. 2018
Design and rationale for the Cardiovascular and Metabolic Effects of Lorcaserin in Overweight and Obese Patients-Thrombolysis in Myocardial Infarction 61 (CAMELLIA-TIMI 61) trial. 202:39-48. 2018
Trends and outcomes of cardiac transplantation from donors dying of drug intoxication. 199:92-96. 2018
Design of DEVOTE (Trial Comparing Cardiovascular Safety of Insulin Degludec vs Insulin Glargine in Patients With Type 2 Diabetes at High Risk of Cardiovascular Events) DEVOTE 1. 179:175-183. 2016
Edoxaban vs warfarin in patients with nonvalvular atrial fibrillation in the US Food and Drug Administration approval population: An analysis from the Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48 (ENGAGE AF-TIMI 48) trial. 172:144-151. 2016
The Palliative Care in Heart Failure Trial: Rationale and design. 168:645-651. 2014
Proceedings from Duke Resistant Hypertension Think Tank. 167:775-U34. 2014
Comment on: "A proposal for new clinical concepts in the management of atrial fibrillation" 2013
A double-blind, randomized, controlled, multicenter study to assess the safety and cardiovascular effects of skeletal myoblast implantation by catheter delivery in patients with chronic heart failure after myocardial infarction. 162:654-U108. 2011
Safety and accuracy of a wireless pulmonary artery pressure monitoring system in patients with heart failure. 161:558-566. 2011
A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure. 161:329-U582. 2011
Arrhythmias in patients with hypoplastic left heart syndrome. 161. 2011
Assessment of the safety and efficacy of the DUETT vascular hemostasis device: Final results of the Safe and Effective Vascular Hemostasis (SEAL) trial. 143:612-619. 2002
First experience with hybrid percutaneous transmyocardial laser revascularization and angioplasty in patients with lesions at high risk for restenosis: Results of a phase 1 feasibility study. 142:679-683. 2001
MULTIHOSPITAL EASTERN ATLANTIC RESTENOSIS TRIAL .2. A PLACEBO-CONTROLLED TRIAL OF THROMBOXANE BLOCKADE IN THE PREVENTION OF RESTENOSIS FOLLOWING CORONARY ANGIOPLASTY. 122:1239-1244. 1991
INFLUENCE OF LEFT-VENTRICULAR FUNCTION ON SIGNAL AVERAGED LATE POTENTIALS IN PATIENTS WITH CORONARY-ARTERY DISEASE WITH AND WITHOUT VENTRICULAR-TACHYCARDIA. 110:747-752. 1985
CLINICAL-EVALUATION OF A NEW TEMPORARY ATRIAL-PACING CATHETER - RESULTS IN 100 PATIENTS. 107:237-240. 1984
PROPOSED PATHOGENESIS OF COR TRIATRIATUM - IMPINGEMENT OF LEFT SUPERIOR VENA-CAVA ON DEVELOPING LEFT ATRIUM. 94:618-626. 1977

category

CARDIAC & CARDIOVASCULAR SYSTEMS Web of Science Category

International Standard Serial Number (ISSN)

0002-8703

Electronic International Standard Serial Number (EISSN)

1097-5330
1097-6744

journal abbreviation

AM HEART J